Keith T. Flaherty

Publishes on Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management. 1.7k papers and 123.3k citations.

PubIndex Score98Top 2%How it's scored

🌟#4 Current Senior Leader in Synthesis of Tetrazole Derivatives

1.7kPublications

123.3kTotal Citations

#4in Synthesis of Tetrazole Derivatives

First publication: 1990First senior author: 1997

Melanoma and MAPK Pathways Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management CAR-T cell therapy research Cancer Genomics and Diagnostics

Top publicationsby citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011

Cited by 7.7k

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Itay Tirosh, Levi A. Garraway, Benjamin Izar et al.|Science|2016

Cited by 5.3k

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty, Paul B. Chapman, Antoni Ribas et al.|New England Journal of Medicine|2010

Cited by 3.5k

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Nir Hacohen, Ryan J. Sullivan et al.|Cell|2018

Cited by 2k

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Gideon Bollag, K. B. Nolop, Peter Hirth et al.|Nature|2010

Cited by 1.8k